Skip to search formSkip to main contentSkip to account menu

CDKN1C gene

Known as: Cyclin-Dependent Kinase Inhibitor 1C Gene, p57(KIP2), CYCLIN-DEPENDENT KINASE INHIBITOR 1C 
This gene plays a regulatory role in the cell cycle.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We present two half siblings with significant short stature who proved a diagnostic challenge for several years. Radiological… 
2015
2015
Downregulation of p57Kip2 is involved in tumor progression, and S-phase kinase-associated protein 2 (Skp2) is an E3 ligase that… 
2013
2013
The p21‐activated kinases have been implicated in the control of cell cycle progression. However, the biological mechanism… 
2013
2013
Imprinted genes have been implicated in early embryonic, placental, and neonatal development and alterations in expression levels… 
2012
2012
CDKN1C and NAP1L4 in human CDKN1C/KCNQ1OT1 imprinted domain are two key candidate genes responsible for BWS (Beckwith-Wiedemann… 
2007
2007
Deer antlers are the only mammalian appendage to display an annual cycle of full regeneration. The growth phase in antler… 
2003
2003
Context: Beckwith–Wiedemann syndrome (BWS) arises by several genetic and epigenetic mechanisms affecting the balance of imprinted… 
2000
2000
Functional defects in the CIP/KIP family of cyclin-dependent kinase inhibitors (CDKIs) have been shown to be associated with… 
2000
2000
In this study we have examined 32 patients with Beckwith Wiedemann Syndrome (BWS) for mutations affecting the CDKN1C gene… 
1999
1999
In this study, we have examined CDKN1C expression in BWS patients with allele imbalance (AI) affecting the 11p15 region. Two of…